We believe that this approach to inhibit PLpro may hinder and reduce the viral ability to perform deISGylation in post COVID-19 viral complications, as well as providing more ISG15 within the lung tissues for the modulation of cytokine/chemokine production, to support the repair of the respiratory epithelium within COVID-19 infections11. The gene discussed is ISG15; the disease is COVID-19.